Literature DB >> 3308942

B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression.

T Kishimoto1.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3308942     DOI： 10.1007/BF00917012

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  88 in total

1.  Relationship between enhanced turnover of phosphatidylinositol and lymphocyte activation by mitogens.

Authors:  V C Maino; M J Hayman; M J Crumpton
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

2.  A monoclonal anti-mouse LFA-1 alpha antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1).

Authors:  G C Mishra; M T Berton; K G Oliver; P H Krammer; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

3.  Regulation of antibody response in vitro. VI. Carrier-specific helper cells for IgG and IgE antibody response.

Authors:  T Kishimoto; K Ishizaka
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

Review 4.  B cell growth and differentiation factors and mechanism of B cell activation.

Authors:  T Kishimoto; K Yoshizaki; M Kimoto; M Okada; T Kuritani; H Kikutani; K Shimizu; T Nakagawa; N Nakagawa; Y Miki
Journal:  Immunol Rev       Date:  1984-04       Impact factor: 12.988

5.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.

Authors:  M Maruyama; H Shibuya; H Harada; M Hatakeyama; M Seiki; T Fujita; J Inoue; M Yoshida; T Taniguchi
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

7.  Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).

Authors:  K Shimizu; T Hirano; K Ishibashi; N Nakano; T Taga; K Sugamura; Y Yamamura; T Kishimoto
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

8.  Translocation of protein kinase C during membrane immunoglobulin-mediated transmembrane signaling in B lymphocytes.

Authors:  Z Z Chen; K M Coggeshall; J C Cambier
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

9.  Abnormal production of and response to B-cell growth factor and B-cell differentiation factor in patients with systemic lupus erythematosus.

Authors:  T Hirose; M Hara; A Kitani; W Hirose; K Norioka; M Kawagoe; H Nakamura
Journal:  Scand J Immunol       Date:  1985-02       Impact factor: 3.487

10.  Anti-immunoglobulin, cytoplasmic free calcium, and capping in B lymphocytes.

Authors:  T Pozzan; P Arslan; R Y Tsien; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539
View more
  28 in total

Review 1.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

Review 2.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

3.  Low MW B-cell growth factor potentiates histamine release from human basophil leucocytes.

Authors:  A Tedeschi; M G Roncarolo; M Lorini; A Miadonna
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

4.  Th17 cells can provide B cell help in autoantibody induced arthritis.

Authors:  Cynthia L Hickman-Brecks; Jennifer L Racz; Debra M Meyer; Timothy P LaBranche; Paul M Allen
Journal:  J Autoimmun       Date:  2010-11-13       Impact factor: 7.094

Review 5.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

6.  Interleukin-6 and renal cell cancer: production, regulation, and growth effects.

Authors:  A S Koo; C Armstrong; B Bochner; T Shimabukuro; C L Tso; J B deKernion; A Belldegrum
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

7.  Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; F Rousset; J Pene; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

Review 8.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

9.  Activation and proliferation of normal resting human T lymphocytes in serum-free culture: role of IL-4 and IL-6.

Authors:  D Habetswallner; E Pelosi; D Bulgarini; A Camagna; P Samoggia; E Montesoro; G Giannella; D Lazzaro; G Isacchi; U Testa
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

10.  Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; G Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.